Skip to content

Clinical trials

Terminated Phase 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 2 Status: Terminated Clear all

86 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20052
20067
20071
20082
200910
20107
20115
20126
20132
20147
20155
20162
20177
20182
20194
20205
20212
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated86

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center7
M.D. Anderson Cancer Center7
Masonic Cancer Center, University of Minnesota6
St. Jude Children's Research Hospital5
National Cancer Institute (NCI)4
H. Lee Moffitt Cancer Center and Research Institute3
City of Hope Medical Center2
Medical College of Wisconsin2
OHSU Knight Cancer Institute2
Roswell Park Cancer Institute2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma86
Leukemia, Myeloid, Acute46
Myelodysplastic Syndromes29
Leukemia, Lymphocytic, Chronic, B-Cell28
Lymphoma, Non-Hodgkin27
Leukemia26
Hodgkin Disease23
Leukemia, Myelogenous, Chronic, BCR-ABL Positive22
Burkitt Lymphoma21
Lymphoma21

Trials

Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.